IDO1 and malignant glioma: The Kyn pathway is mediated primarily by the catalytic activities of indoleamine 2,3-dioxygenase (IDO) found in many immune cells and tryptophan 2,3-dioxygenase (TDO) expressed constitutively in certain types of cancer such as malignant glioma and hepatocellular carcinoma26.